California Public Employees Retirement System’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-22,400
Closed -$2.95M 3562
2020
Q4
$2.95M Sell
22,400
-500
-2% -$44.2K ﹤0.01% 1750
2020
Q3
$1.16M Sell
22,900
-2,138
-9% -$96.1K ﹤0.01% 2176
2020
Q2
$1.19M Sell
25,038
-900
-3% -$41.9K ﹤0.01% 2113
2020
Q1
$1.27M Buy
25,938
+2,800
+12% +$143K ﹤0.01% 1859
2019
Q4
$1.33M Buy
23,138
+807
+4% +$40K ﹤0.01% 2226
2019
Q3
$803K Buy
+22,331
New +$872K ﹤0.01% 2386

California Public Employees Retirement System's EIDX Position: Q1 2021 in Review

California Public Employees Retirement System sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 22,400 shares — an estimated $2.95M sold.

California Public Employees Retirement System first reported a position in EIDX in Q3 2019 and held it in 6 quarters. The position peaked at $2.95M in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

  • California Public Employees Retirement System reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 22,400 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $2.95M.
  • California Public Employees Retirement System first reported a position in Eidos Therapeutics, Inc. Common Stock in Q3 2019 and held it in 6 quarters.
  • California Public Employees Retirement System's Eidos Therapeutics, Inc. Common Stock position peaked at $2.95M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on California Public Employees Retirement System's 13F filing for Q1 2021, filed 14 May 2021.